DE69505804D1 - Afamin: ein menschliches serum albumin ähnliches protein - Google Patents
Afamin: ein menschliches serum albumin ähnliches proteinInfo
- Publication number
- DE69505804D1 DE69505804D1 DE69505804T DE69505804T DE69505804D1 DE 69505804 D1 DE69505804 D1 DE 69505804D1 DE 69505804 T DE69505804 T DE 69505804T DE 69505804 T DE69505804 T DE 69505804T DE 69505804 D1 DE69505804 D1 DE 69505804D1
- Authority
- DE
- Germany
- Prior art keywords
- human serum
- protein
- serum albumin
- afamin
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/222,619 US5652352A (en) | 1994-03-31 | 1994-03-31 | Afamin: a human serum albumin-like gene |
PCT/US1995/004075 WO1995027059A1 (en) | 1994-03-31 | 1995-03-31 | Afamin: a human serum albumin-like protein |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69505804D1 true DE69505804D1 (de) | 1998-12-10 |
DE69505804T2 DE69505804T2 (de) | 1999-07-08 |
Family
ID=22832990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69505804T Expired - Fee Related DE69505804T2 (de) | 1994-03-31 | 1995-03-31 | Afamin: ein menschliches serum albumin ähnliches protein |
Country Status (11)
Country | Link |
---|---|
US (2) | US5652352A (de) |
EP (1) | EP0754229B1 (de) |
JP (1) | JPH09511399A (de) |
AT (1) | ATE173014T1 (de) |
AU (1) | AU691607B2 (de) |
CA (1) | CA2186516A1 (de) |
DE (1) | DE69505804T2 (de) |
DK (1) | DK0754229T3 (de) |
ES (1) | ES2123973T3 (de) |
MX (1) | MX9604402A (de) |
WO (1) | WO1995027059A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060014143A1 (en) * | 1995-06-07 | 2006-01-19 | Nobuto Yamamoto | Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
US6410269B1 (en) * | 1995-06-07 | 2002-06-25 | Nobuto Yamamoto | Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
US7208576B2 (en) * | 1999-01-06 | 2007-04-24 | Merrimack Pharmaceuticals, Inc. | Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
AT407675B (de) * | 1999-06-25 | 2001-05-25 | Vita Tech Illmensee Dieplinger | Verfahren zur fertilitätsbestimmung von säugetieren, insbesondere von menschen |
CA2440582A1 (en) * | 2001-03-09 | 2002-10-03 | Dyax Corp. | Serum albumin binding moieties |
AT411014B (de) * | 2001-04-30 | 2003-09-25 | Vitateq Biotechnology Gmbh | Präparationen von vitamin e in kombination mit afamin |
EP1997829A1 (de) | 2001-12-21 | 2008-12-03 | Human Genome Sciences, Inc. | Albumin Fusionsproteine |
AU2003276061A1 (en) * | 2002-06-14 | 2003-12-31 | Dyax Corporation | Protein analysis |
JP4492156B2 (ja) * | 2004-03-03 | 2010-06-30 | ニプロ株式会社 | 血清アルブミンドメインを含む蛋白質 |
AT501348B1 (de) * | 2005-01-31 | 2008-10-15 | Vitateq Biotechnology Gmbh | Verfahren zur tumordiagnose |
WO2007146385A2 (en) * | 2006-06-14 | 2007-12-21 | Johns Hopkins University | Albumin-bound protein/peptide complex as a biomarker for disease |
AT505727B1 (de) | 2007-09-04 | 2009-06-15 | Univ Innsbruck | Verfahren zur diagnose des metabolischen syndroms |
WO2013000992A1 (en) | 2011-06-28 | 2013-01-03 | Vitateq Biotechnology Gmbh | Method for diagnosing preeclampsia |
GB2511525A (en) * | 2013-03-05 | 2014-09-10 | Randox Teoranta | Methods and Compositions for the Diagnosis of Alzheimer's Disease |
JP2016188761A (ja) * | 2013-08-23 | 2016-11-04 | 国立研究開発法人国立国際医療研究センター | 糖尿病腎症の発症または発症リスクの検出方法及びキット |
EP3037824A1 (de) | 2014-12-22 | 2016-06-29 | Vitateq Biotechnology GmbH | Verfahren zur Detektion und/oder Quantifizierung von Afamin |
US10550364B2 (en) | 2014-12-24 | 2020-02-04 | Osaka University | Method for producing Wnt protein and method for storing Wnt protein |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1226551B (it) * | 1988-07-29 | 1991-01-24 | Sclavo Spa | Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita' verso l'alfa- fetoproteina e loro impiego in campo diagnostico |
US6268212B1 (en) * | 1993-10-18 | 2001-07-31 | Amgen Inc. | Tissue specific transgene expression |
-
1994
- 1994-03-31 US US08/222,619 patent/US5652352A/en not_active Expired - Lifetime
-
1995
- 1995-03-31 AU AU22367/95A patent/AU691607B2/en not_active Ceased
- 1995-03-31 WO PCT/US1995/004075 patent/WO1995027059A1/en active IP Right Grant
- 1995-03-31 EP EP95915503A patent/EP0754229B1/de not_active Expired - Lifetime
- 1995-03-31 DE DE69505804T patent/DE69505804T2/de not_active Expired - Fee Related
- 1995-03-31 AT AT95915503T patent/ATE173014T1/de not_active IP Right Cessation
- 1995-03-31 JP JP7525892A patent/JPH09511399A/ja active Pending
- 1995-03-31 DK DK95915503T patent/DK0754229T3/da active
- 1995-03-31 CA CA002186516A patent/CA2186516A1/en not_active Abandoned
- 1995-03-31 ES ES95915503T patent/ES2123973T3/es not_active Expired - Lifetime
- 1995-03-31 MX MX9604402A patent/MX9604402A/es unknown
-
1997
- 1997-03-13 US US08/816,920 patent/US5767243A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2236795A (en) | 1995-10-23 |
MX9604402A (es) | 1997-07-31 |
ES2123973T3 (es) | 1999-01-16 |
EP0754229B1 (de) | 1998-11-04 |
EP0754229A1 (de) | 1997-01-22 |
CA2186516A1 (en) | 1995-10-12 |
JPH09511399A (ja) | 1997-11-18 |
DK0754229T3 (da) | 1999-07-19 |
US5652352A (en) | 1997-07-29 |
DE69505804T2 (de) | 1999-07-08 |
WO1995027059A1 (en) | 1995-10-12 |
US5767243A (en) | 1998-06-16 |
ATE173014T1 (de) | 1998-11-15 |
AU691607B2 (en) | 1998-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE173014T1 (de) | Afamin: ein menschliches serum albumin ähnliches protein | |
BG104149A (en) | Interleukin-18-binding proteins, methods for their preparation and administration | |
DE69131580D1 (de) | GDF-1 und UOG1 Proteine | |
ATE389666T1 (de) | Hohe expressionsrate von proteinen | |
AU8747791A (en) | Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis | |
DK0807178T3 (da) | Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose | |
ATE285474T1 (de) | Haemophilus adhäsionsproteinen | |
MX9602557A (es) | Proteinas de higado de mamifero y su uso en oncologia. | |
DE69524971D1 (de) | Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen | |
ATE139541T1 (de) | Kollagen-bindendes protein sowie dessen herstellung | |
SE9602822D0 (sv) | New receptor | |
AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
TR200000416T2 (tr) | Neisseria loctoferrin bağlayıcı protein. | |
DK1431391T3 (da) | RANTES-mutanter og terapeutiske anvendelser heraf | |
CA2199403A1 (en) | Novel PKA-Binding Proteins and Uses Thereof | |
WO1996016170A3 (en) | Proteins involved in the regulation of cell-cell adhesion and uses thereof | |
WO1992011367A3 (en) | Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof | |
DE69929683D1 (de) | Antisense modulierung von lfa-3 | |
CA2199843A1 (en) | Novel PKA-Binding Proteins and Uses Thereof | |
ATE315646T1 (de) | Leukocyten-aktivierender faktor | |
NZ503256A (en) | Isolated proteins having retinol dehydrogenase activity, and which associate with retinol binding protein receptors | |
SE9604439D0 (sv) | New receptor | |
WO2001018194A3 (en) | Maize casein kinase 1 orthologue and uses thereof | |
ATE130872T1 (de) | Ancrod ähnliche proteine, ihre herstellung und verwendung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |